Renovacor, Inc.
(NYSE Amex Equities : RCOR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 8.53%147.380.0%$973.12m
AMGNAmgen, Inc. 0.83%255.151.5%$859.05m
GILDGilead Sciences, Inc. 0.04%64.501.0%$545.08m
VRTXVertex Pharmaceuticals, Inc. 1.33%273.251.9%$494.23m
REGNRegeneron Pharmaceuticals, Inc. 1.10%690.932.6%$439.30m
ILMNIllumina, Inc. 5.13%256.073.3%$329.55m
NVAXNovavax, Inc. 17.48%55.3075.7%$303.63m
BIIBBiogen, Inc. 0.41%205.051.8%$233.65m
BNTXBioNTech SE 4.62%165.460.0%$220.74m
SNSSSunesis Pharmaceuticals, Inc. 2.86%2.160.7%$150.99m
EXASEXACT Sciences Corp. 7.16%53.4317.7%$137.38m
TXG10X Genomics, Inc. 13.16%53.580.0%$107.62m
TECHBio-Techne Corp. 5.38%384.964.5%$105.70m
BMRNBioMarin Pharmaceutical, Inc. 2.28%80.664.2%$96.70m
CRSPCRISPR Therapeutics AG 5.25%58.130.6%$84.62m

Company Profile

Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA.